Showing results (1221-1230 of 2,709) with videos related to

Sort By:
Pageof 271
The Lancet. Infectious Diseases|June 11, 2019
Efficacy of live oral rotavirus vaccines by duration of follow-up: a meta-regression of randomised controlled trialsAndrew Clark, Kevin van Zandvoort, Stefan Flasche, et al.
The Lancet. Infectious Diseases|August 28, 2012
Cross-protective efficacy of two human papillomavirus vaccines: a systematic review and meta-analysisTalía Malagón, Mélanie Drolet, Marie-Claude Boily, et al.
The Lancet. Infectious Diseases|March 20, 2015
Effects of oseltamivir treatment of index patients with influenza on secondary household illness in an urban setting in Bangladesh: secondary analysis of a randomised, placebo-controlled trialAlicia M Fry, Doli Goswami, Kamrun Nahar, et al.
The Lancet. Infectious Diseases|August 2, 2021
Effect on genital warts in Australian female and heterosexual male individuals after introduction of the national human papillomavirus gender-neutral vaccination programme: an analysis of national sentinel surveillance data from 2004-18Eric P F Chow, Allison Carter, Tobias Vickers, et al.
The Lancet. Infectious Diseases|January 26, 2023
Novel severe oculocutaneous manifestations of human monkeypox virus infection and their historical analoguesSteven Carrubba, Alexi Geevarghese, Elena Solli, et al.
The Lancet. Infectious Diseases|August 14, 2022
Age-sex differences in the global burden of lower respiratory infections and risk factors, 1990-2019: results from the Global Burden of Disease Study 2019
The Lancet. Infectious Diseases|August 21, 2025
A clinical practice guideline for tuberculous meningitisJoseph Donovan, Fiona V Cresswell, Elizabeth W Tucker, et al.
The Lancet. Infectious Diseases|March 3, 2023
Clinical implications of molecular drug resistance testing for Mycobacterium tuberculosis: a 2023 TBnet/RESIST-TB consensus statementJosé Domínguez, Martin J Boeree, Emmanuelle Cambau, et al.
The Lancet. Infectious Diseases|November 10, 2022
Efficacy and safety of moxidectin and albendazole compared with ivermectin and albendazole coadministration in adolescents infected with Trichuris trichiura in Tanzania: an open-label, non-inferiority, randomised, controlled, phase 2/3 trialSophie Welsche, Emmanuel C Mrimi, Jan Hattendorf, et al.
The Lancet. Infectious Diseases|August 11, 2022
Respiratory syncytial virus prevention within reach: the vaccine and monoclonal antibody landscapeNatalie I Mazur, Jonne Terstappen, Ranju Baral, et al.
Pageof 271